Research Online
metadata only
A blood-based predictor for neocortical Aβ burden in Alzheimer's disease: results from the AIBL study
Dementia is a global epidemic with Alzheimer’s disease (AD) being the leading cause. Early identification of patients at risk of developing AD is now becoming an international priority. Neocortical Aβ (extracellular β-amyloid) burden (NAB), as assessed by positron emission tomography (PET), represen
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- MRI detects blood-brain barrier alterations in a rat model of Alzheimer’s disease and lung infection#274370
- Developing Advanced Blood-Brain Barrier Permeability Imaging for Early AD#903489
- Clinical impact of the Alzheimer's Disease Neuroimaging Initiative: A review of studies using ADNI data (2023 to June 2025).#28212
- Biomarker-based Trial of NPC-1 for Alzheimer's Pathology#897412
- StrokeCog-BBB to Study Cognitive Outcomes Following Stroke#878025
Record · ID 1081707
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive